Poland· PL-100461459
Vosevi
A medicinal product containing sofosbuvirum + velpatasvirum + voxilaprevirum, registered in Poland by Gilead Sciences Ireland UC.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Sofosbuvirum + Velpatasvirum + Voxilaprevirum
- Manufacturer
- Gilead Sciences Ireland UC
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sofosbuvirum + velpatasvirum + voxilaprevirum in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVOSEVIGilead Sciences Ireland UC, Carrigtohill
- IcelandVoseviGilead Sciences Ireland UC*
- NetherlandsVosevi 200 mg/50 mg/50 mg, filmomhulde tablettenGilead Sciences Ireland UC
- FinlandVoseviGilead Sciences Ireland UC
- SwedenVosevi 200 mg/50 mg/50 mg Filmdragerad tablettGilead Sciences Ireland UC
- IrelandVosevi 200 mg/50 mg/50 mg film-coated tabletsGilead Sciences Ireland UC
- CanadaVOSEVIGILEAD SCIENCES CANADA INC
- United StatesVoseviGilead Sciences, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vosevi
- Liechtenstein · Vosevi
- Norway · Vosevi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/71271564-8fe6-4a1f-be35-d879131b6f73 GET /v1/drugs/71271564-8fe6-4a1f-be35-d879131b6f73?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "200 mg + 50 mg + 50 mg",
"packaging": "Rpz ¦ EU/1/17/1223/002 ¦ 142792\n28 tabl.",
"substance": "Sofosbuvirum 200 mg + Velpatasvirum 50 mg + Voxilaprevirum 50 mg",
"common_name": "Sofosbuvirum + Velpatasvirum + Voxilaprevirum",
"pl_product_id": "100461459",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about sofosbuvirum + velpatasvirum + voxilaprevirum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.